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Potential Liability for Physicians Using Artificial Intelligence
Artificial intelligence (AI) is quickly making inroads into
medical practice, especially in forms that rely on machine learning, with a mix of hope and hype.1 Multiple
AI-based products have now been approved or cleared
bytheUSFoodandDrugAdministration(FDA),andhealth
systems and hospitals are increasingly deploying
AI-based systems.2 For example, medical AI can support
clinical decisions, such as recommending drugs or dosages or interpreting radiological images.2 One key difference from most traditional clinical decision support software is that some medical AI may communicate results
or recommendations to the care team without being able
to communicate the underlying reasons for those results.3
Medical AI may be trained in inappropriate environments, using imperfect techniques, or on incomplete
data. Even when algorithms are trained as well as possible, they may, for example, miss a tumor in a radiological image or suggest the incorrect dose for a drug or an
inappropriate drug. Sometimes, patients will be injured as a result. In this Viewpoint, we discuss when
a physician could likely be held liable under current law
when using medical AI.

Such a recommendation would be consistent with one
of the goals of some AI, to personalize care.
Next, the physician could either follow or reject the
AI recommendation (column 4). In this example, the physician retains this discretion, although in the future a
health system or a payer may limit physician discretion.
Column 5 represents the patient outcome. If the physician follows a correct recommendation or rejects an incorrect recommendation, the outcome is good; if the opposite, the outcome is bad (in this very stylized example).
Eight possible scenarios result (column 6). The law
treats them differently, and understanding these differences rests on some basic elements of US tort law. First,
if there is no injury, there will be no liability (green boxes
in the Figure); this is a good outcome, whether it happens because the physician accepts a correct recommendation (scenarios 1 and 5) or rejects an incorrect recommendation (scenarios 4 and 8).
Second, tort law typically privileges the standard of
care, regardless of its effectiveness in a particular case—
ie, whether providing that care leads to a good or bad
outcome. When physicians follow the standard of care
(eg, 15 mg/kg of bevacizumab every 3 weeks; scenarios
1, 3, 6, and 8), they will not generally be held liable for a
Medical AI and Liability for Physicians
In general, to avoid medical malpractice liability, physi- bad outcome, even if a different course of action would
cians must provide care at the level of a competent have been better for a particular patient in a particular
physician within the same specialty, taking into account case (yellow boxes in the Figure).
available resources.4 The situation becomes more comThus, under current law, a physician faces liability only
plicated when an AI algorithmic recommendation when she or he does not follow the standard of care and
becomes involved. In part because AI is so new to clini- an injury results (red boxes in the Figure).
This analysis suggests an important
implication for physicians using medical
The challenge is that current law
AI to aid their clinical decisions: because
current law shields physicians from liabilincentivizes physicians to minimize
ity as long as they follow the standard of
the potential value of AI.
care, the “safest” way to use medical AI
cal practice, there is essentially no case law on liability from a liability perspective is as a confirmatory tool to
involving medical AI. Nonetheless, it is possible to support existing decision-making processes, rather than
understand how current law may be likely to treat as a source of ways to improve care.
these situations from more general tort law principles.
Although many physicians may be comfortable with
The Figure presents potential outcomes for a simple this approach, the challenge is that current law inceninteraction—for instance, when an AI recommends the tivizes physicians to minimize the potential value of AI.
drug and dosage for a patient with ovarian cancer. As- If the medical AI performs a task better than the physisume the standard of care for this patient would be to cian, such as recommending a higher dosage of a drug,
administer 15 mg/kg every 3 weeks of the chemothera- it will provide some results different than the physipeutic bevacizumab.
cian. The difference will increase if, in the future, some
The first question (column 2) is what the AI recom- medical AIs perform better than even the best physimends. To simplify, assume the AI makes 1 of 2 recom- cians, a goal for some algorithms. But because threat of
mendations (there could be many more in clinical care): liability encourages physicians to meet and follow the
the standard-of-care dosage or a much higher dosage: standard of care, they may reject such recommenda75 mg/kg every 3 weeks.
tions and thus fail to realize the full value of AI, in some
The AI could be correct or incorrect either way cases to patients’ detriment.
(column 3). Even though 15 mg/kg every 3 weeks is
The legal standard of care is key to liability for medithe standard-of-care dosage, perhaps for some reason cal AI, but it is not forever fixed. Over time, the standard
the higher dosage is right for this particular patient. ofcaremayshift.Whathappensifmedicalpracticereaches
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Figure. Examples of Potential Legal Outcomes Related to AI Use in Clinical Practice
Scenario AI recommendation AI accuracy
Standard of care

Correct

Physician action Patient outcome Legal outcome (probable)
Follows

Good

No injury and no liability

2

Rejects

Bad

Injury and liability

3

Incorrect (standard Follows
of care is incorrect) Rejects

Bad

Injury but no liability

Good

No injury and no liability

Good

No injury and no liability

6

Correct (standard Follows
of care is incorrect) Rejects

Bad

Injury but no liability

7

Incorrect

Follows

Bad

Injury and liability

Rejects

Good

No injury and no liability

1

4
5

Nonstandard care

8

a point where AI becomes part of the standard of care, the consensus
view of good medical practice?4 If and when that happens, scenarios
6 and 7 (italicized text in the Figure) may change substantially: physicians may incur liability for rejecting correct but nonstandard AI recommendationsandmayconverselyavoidliabilityforinjuryiftheywere
following incorrect AI recommendations. Because tort law is inherently conservative, the second alternative (scenario 7) is a more likely
first step: reliance on medical AI to deviate from the otherwise known
standard of care will likely be a defense to liability well before physicians are held liable for rejecting AI recommendations. But physicians
should watch this space because it may change quickly.

What Should Physicians Do?
Physicians have a substantial role in shaping the liability issue. In their
practices, physicians should learn how to better use and interpret
AI algorithms, including in what situations an available medical AI
should be applied and how much confidence should be placed in an
algorithmic recommendation. This is a challenge, and evaluation tools
are still very much under development.
Physicians should also encourage their professional organizations to take active steps to evaluate practice-specific algorithms.
Review by the FDA will provide some quality assurance, but societies will be well placed to provide additional guidelines to evaluate AI products at implementation and to evaluate AI recommendations for individual patients. The analogy to practice guidelines
is strong; much as societies guide the standard of care for specific
interventions, they can guide practices for adopting and using medical AI reliably, safely, and effectively.
As part of care settings, such as in hospitals and health systems, physicians should also ensure that administrative efforts
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AI indicates artificial intelligence.

to develop and deploy algorithms reflect what is truly needed in
clinical care. When external AI products are procured, physicians
should advocate for safeguards to ensure that such products are
rigorously vetted before procurement, just as with other novel
medical devices.
In addition, physicians should check carefully with their malpractice insurer to determine how the insurer covers the use of medical AI in practice. Is care that relies on AI recommendations covered the same as care without such recommendations, or does the
insurer treat such practices differently? Are practices different for
more opaque algorithms that provide little or no reasoning? Collectively, physicians and their hospital systems may be able to make demands for changes in terms of insurance coverage to better accommodate the needs of a future of AI-enabled medicine.
Although current law around physician liability and medical AI
is complex, the problem becomes far more complex with the recognition that physician liability is only one piece of a larger ecosystem of liability. Hospital systems that purchase and implement medical AI, makers of medical AI, and potentially even payers could all
face liability.5 The scenarios outlined in the Figure and the fundamental questions highlighted here recur and interact for each of these
forms of liability. Moreover, the law may change; in addition to AI
becoming the standard of care, which may happen through ordinary legal evolution, legislatures could impose very different rules,
such as a no-fault system like the one that currently compensates
individuals who have vaccine injuries.
As AI enters medical practice, physicians need to know how law
will assign liability for injuries that arise from interaction between
algorithms and practitioners. These issues are likely to arise sooner
rather than later.
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